Your browser is no longer supported. Please, upgrade your browser.
ANGO AngioDynamics, Inc. monthly Stock Chart
ANGO [NASD]
AngioDynamics, Inc.
Index- P/E129.55 EPS (ttm)0.13 Insider Own1.60% Shs Outstand36.47M Perf Week4.52%
Market Cap623.64M Forward P/E23.17 EPS next Y0.74 Insider Trans-88.92% Shs Float36.09M Perf Month8.57%
Income5.00M PEG10.00 EPS next Q0.16 Inst Own94.70% Short Float4.74% Perf Quarter10.32%
Sales349.60M P/S1.78 EPS this Y111.20% Inst Trans-3.64% Short Ratio8.50 Perf Half Y3.45%
Book/sh14.00 P/B1.22 EPS next Y9.82% ROA0.70% Target Price17.67 Perf Year6.41%
Cash/sh1.34 P/C12.81 EPS next 5Y12.95% ROE1.00% 52W Range14.80 - 18.18 Perf YTD1.36%
Dividend- P/FCF11.20 EPS past 5Y21.60% ROI1.30% 52W High-5.94% Beta1.11
Dividend %- Quick Ratio1.40 Sales past 5Y9.50% Gross Margin50.40% 52W Low15.54% ATR0.44
Employees1250 Current Ratio2.20 Sales Q/Q-7.00% Oper. Margin3.70% RSI (14)60.85 Volatility1.81% 2.44%
OptionableYes Debt/Eq0.19 EPS Q/Q70.30% Profit Margin1.40% Rel Volume2.29 Prev Close17.05
ShortableYes LT Debt/Eq0.18 EarningsJul 18 BMO Payout0.00% Avg Volume201.16K Price17.10
Recom2.80 SMA203.64% SMA505.63% SMA2004.66% Volume459,833 Change0.29%
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-30-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-08-17Initiated Barclays Equal Weight $17
Nov-04-16Initiated Cantor Fitzgerald Buy
Apr-08-16Resumed Piper Jaffray Neutral
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Jun-14-11Downgrade Wedbush Neutral → Underperform $14 → $12
Sep-08-10Reiterated Wedbush Neutral $17.50 → $14
Mar-04-10Initiated Wedbush Morgan Neutral $17.50
Sep-04-09Reiterated Caris & Company Above Average $13 → $15
Jul-17-09Reiterated Caris & Company Above Average $15 → $13
Jan-07-09Downgrade Caris & Company Buy → Above Average $20 → $15
Nov-13-08Initiated Stifel Nicolaus Hold
Aug-18-17 04:20PM  ETFs with exposure to AngioDynamics, Inc. : August 18, 2017 Capital Cube
03:41AM  AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue? Zacks
Aug-12-17 11:40PM  Edited Transcript of ANGO earnings conference call or presentation 18-Jul-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-08-17 09:52AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017 Capital Cube
Aug-07-17 07:49AM  AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference GlobeNewswire
Jul-27-17 04:25PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
Jul-26-17 09:19AM  INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO PR Newswire
Jul-24-17 06:56PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire +7.35%
01:21PM  Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc. PR Newswire
Jul-21-17 05:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO Accesswire
Jul-19-17 09:08AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017 Capital Cube
09:08AM  AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat Zacks
Jul-18-17 06:23PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -6.78%
06:21PM  ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations Business Wire
05:43PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of AngioDynamics, Inc. Business Wire
04:49PM  AngioDynamics reports 4Q loss Associated Press
03:28PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
02:32PM  ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm PR Newswire
02:11PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO) PR Newswire
01:05PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
12:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO PR Newswire
06:00AM  AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results GlobeNewswire
Jul-07-17 06:00AM  AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results GlobeNewswire
Jun-15-17 04:06PM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : June 15, 2017 Capital Cube
01:03PM  ETFs with exposure to AngioDynamics, Inc. : June 15, 2017 Capital Cube
Jun-14-17 08:20AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : June 14, 2017 Capital Cube
Jun-09-17 08:15AM  Featured Company News - Medical Devices Company AngioDynamics Receives FDA Clearance for Solero MTA System Accesswire
Jun-07-17 06:00AM  AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System GlobeNewswire
May-31-17 03:48PM  Albany public company files lawsuit alleging competitor violated antitrust laws American City Business Journals
06:00AM  AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access GlobeNewswire
May-09-17 06:00AM  AngioDynamics to Present at the 2017 UBS Global Healthcare Conference GlobeNewswire
May-01-17 03:11AM  AngioDynamics (ANGO) Down 11.7% Since Earnings Report: Can It Rebound? Zacks
Apr-20-17 06:00AM  AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference GlobeNewswire
Apr-10-17 10:06AM  AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering Zacks
08:32AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : April 10, 2017 Capital Cube
Apr-07-17 09:25AM  Endo international, AngioDynamics Lead Biotech Movers TheStreet.com
Apr-06-17 07:49PM  AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders GlobeNewswire
04:02PM  AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders GlobeNewswire
Apr-05-17 04:18PM  ETFs with exposure to AngioDynamics, Inc. : April 5, 2017 Capital Cube
Apr-04-17 05:54PM  5 Cheap Value Stocks to Tame a Capricious Market in Q2 Zacks
09:23AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2017 By the Numbers : April 4, 2017 Capital Cube
Apr-03-17 10:57AM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report
Mar-31-17 11:04AM  AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View Zacks
Mar-30-17 07:32PM  Edited Transcript of ANGO earnings conference call or presentation 30-Mar-17 12:00pm GMT Thomson Reuters StreetEvents
01:35PM  AngioDynamics downgraded by KeyBanc Capital Mkts
08:02AM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q3 2017 AngioDynamics Inc Earnings Release - Before Market Open
06:12AM  AngioDynamics tops 3Q profit forecasts Associated Press
06:00AM  AngioDynamics Reports Fiscal 2017 Third Quarter Results GlobeNewswire
Mar-29-17 10:45AM  Here's Why You Should Steer Clear of Mednax (MD) for Now
10:45AM  Here's Why You Should Steer Clear of Mednax (MD) for Now Investopedia
Mar-27-17 06:55AM  AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City GlobeNewswire
Mar-20-17 06:00AM  AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results GlobeNewswire
Mar-15-17 10:12AM  AngioDynamics Microwave Tissue Ablation System Now CE Marked
Mar-14-17 06:00AM  AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System GlobeNewswire
Mar-13-17 09:02AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : March 13, 2017
Mar-08-17 09:26AM  AngioDynamics to Present at the Barclays Global Healthcare Conference GlobeNewswire
Jan-20-17 08:32AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : January 20, 2017
Jan-19-17 12:13PM  ETFs with exposure to AngioDynamics, Inc. : January 19, 2017
Jan-17-17 08:14AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2017 By the Numbers : January 17, 2017
Jan-12-17 01:04PM  ANGIODYNAMICS INC Financials
Jan-11-17 08:15AM  Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Accesswire
Jan-10-17 11:18AM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-09-17 09:51AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
08:03AM  AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View
Jan-06-17 02:46PM  Edited Transcript of ANGO earnings conference call or presentation 6-Jan-17 1:00pm GMT
12:01PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q2 2017 AngioDynamics Inc Earnings Release - Before Market Open
06:08AM  AngioDynamics beats 2Q profit forecasts
06:00AM  AngioDynamics Reports Fiscal 2017 Second Quarter Results GlobeNewswire
Jan-03-17 06:00AM  AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-20-16 06:00AM  AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results GlobeNewswire
Dec-16-16 12:13AM  How Nantkwest Inc (NK) Stacks Up Versus Peers at Insider Monkey
Dec-09-16 11:09AM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : December 9, 2016
08:28AM  Is NeoGenomics, Inc. (NEO) A Good Stock To Buy? at Insider Monkey
Dec-08-16 01:14PM  Should You Follow the Smart Money Surge into AngioDynamics, Inc. (ANGO)? at Insider Monkey
07:20AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : December 8, 2016
Nov-29-16 03:30PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors Accesswire
Nov-28-16 11:31AM  ETFs with exposure to AngioDynamics, Inc. : November 28, 2016
09:30AM  Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks
06:00AM  AngioDynamics to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-25-16 07:05AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 25, 2016
Nov-18-16 04:09PM  ANGIODYNAMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-16-16 09:58AM  AngioDynamics (ANGO) Announces 2.5M Secondary Offering
Nov-15-16 01:09PM  ETFs with exposure to AngioDynamics, Inc. : November 15, 2016
Nov-14-16 07:53PM  AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders GlobeNewswire
04:09PM  AngioDynamics Announces Secondary Offering of 2,500,000 Shares of Common Stock by Selling Stockholders GlobeNewswire
11:12AM  Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capitals Investment Moves? at Insider Monkey
07:58AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 14, 2016
Nov-10-16 04:12PM  ANGIODYNAMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitiv
09:30AM  The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding
Nov-09-16 06:01AM  AngioDynamics Announces New Senior Credit Facilities and New Share Repurchase Program GlobeNewswire
06:00AM  AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc. GlobeNewswire
Nov-07-16 06:00AM  AngioDynamics to Present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum GlobeNewswire
Nov-03-16 10:14AM  Becton, Dickinson (BDX) Beats on Q4 Earnings & Revenues
07:19AM  Luminex (LMNX) Misses Q3 Earnings Estimates, '16 View Up
06:53AM  Healthways (HWAY) Misses Q3 Earnings, Revenue Estimates
Nov-02-16 10:49AM  Integer (ITGR) Beats Earnings and Revenue Estimates in Q3
10:03AM  Fresenius Medical (FMS) Q3 Earnings, Sales Beat Estimates
Nov-01-16 02:31PM  Abiomed (ABMD) Q2 Earnings Lag Estimates, Revenues Beat
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSON WESLEYDirectorJul 25Option Exercise15.7514,000220,50060,974Aug 08 05:48 PM
Meteny Dennis SDirectorJul 25Option Exercise15.7514,000220,50083,127Aug 08 05:44 PM
GOLD JEFFREYDirectorJul 25Option Exercise15.7514,000220,50066,037Jul 28 03:47 PM
REED JAN STERNDirectorJul 24Buy16.003165,056316Jul 25 02:33 PM
DONNELLY HOWARD WDirectorJul 21Buy15.725,00078,60047,600Jul 21 09:46 PM
Clemmer James CPresident and CEOJul 21Buy15.795,00078,95091,683Jul 21 06:43 PM
Clemmer James CPresident and CEOJul 20Buy15.6420,000312,80086,683Jul 21 06:43 PM
DONNELLY HOWARD WDirectorJun 19Option Exercise15.7514,000220,50056,144Jun 21 09:42 PM
Burgstahler David FDirectorApr 12Sale16.002,350,00037,600,000381,406Apr 14 04:48 PM
Avista Capital Partners GP, LL10% OwnerApr 12Sale16.002,350,00037,600,000381,406Apr 14 04:40 PM
LaPorte SteveDirectorJan 13Option Exercise15.7514,000220,50048,201Jan 17 02:34 PM
Avista Capital Partners GP, LL10% OwnerNov 18Sale15.682,091,29432,791,4901,014,058Nov 22 04:20 PM
Burgstahler David FDirectorNov 18Sale15.682,091,29432,791,4901,014,058Nov 22 04:21 PM
Meteny Dennis SDirectorAug 31Option Exercise13.2912,000159,48070,793Sep 06 06:54 PM
GOLD JEFFREYDirectorAug 31Option Exercise13.2912,000159,48061,679Sep 06 06:51 PM